Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov 2;73(9):e2819-e2820.
doi: 10.1093/cid/ciaa1565.

Cryptococcal Antigenemia and the Implications of Viral Load-Directed Cryptococcal Antigen Screening in Antiretroviral Therapy-Experienced Patients With Human Immunodeficiency Virus

Affiliations
Comment

Cryptococcal Antigenemia and the Implications of Viral Load-Directed Cryptococcal Antigen Screening in Antiretroviral Therapy-Experienced Patients With Human Immunodeficiency Virus

Heather N Paulin et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.

Comment in

  • Reply to the Author.
    Mpoza E, Meya DB. Mpoza E, et al. Clin Infect Dis. 2021 Nov 2;73(9):e2820. doi: 10.1093/cid/ciaa1566. Clin Infect Dis. 2021. PMID: 33069167 Free PMC article. No abstract available.

Comment on

References

    1. World Health Organization. Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. WHO Guidelines Approved by the Guidelines Review Committee. Geneva, Switzerland: WHO, 2018. - PubMed
    1. World Health Organization. Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. WHO guidelines approved by the Guidelines Review Committee. Geneva, Switzerland: WHO, 2017. - PubMed
    1. Mpoza E, Rajasingham R, Tugume L, et al. Cryptococcal antigenemia in HIV therapy-experienced Ugandans with virologic failure. Clin Infect Dis. 2020; 71:1726–31. - PMC - PubMed
    1. Meya DB, Kiragga AN, Nalintya E, et al. Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4 <100 cells/μL: a stepped-wedge, cluster-randomized trial. J Acquir Immune Defic Syndr 2019; 80:182–9. - PMC - PubMed
    1. Rhein J, Hullsiek KH, Evans EE, et al.; ASTRO-CM Study Team. Detrimental outcomes of unmasking cryptococcal meningitis with recent ART initiation. Open Forum Infect Dis 2018; 5:ofy122. - PMC - PubMed

Substances